Manhattan Pharmaceuticals to Present Preliminary Phase I Obesity Drug Data at 2005 Annual Meeting of NAASO
14 oct. 2005 08h27 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (AMEX:MHA) will present preliminary Phase I results of its obesity drug candidate, Oleoyl-estrone (OE), an experimental, orally...
Manhattan Pharmaceuticals Shares to Trade on the American Stock Exchange
06 oct. 2005 09h36 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Oct. 6, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) common shares are expected to begin trading on the American Stock Exchange tomorrow October 7 under the symbol...
Manhattan Pharmaceuticals to Present at ValueRich Small-cap Financial Expo
14 sept. 2005 16h25 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 14, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc.'s (OTCBB:MHTT) president and chief executive officer, Douglas Abel, will present an overview of the company and its obesity...
Manhattan Pharmaceuticals Obesity Drug Safe in Phase Ia Study
07 sept. 2005 12h29 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 7, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) said Oleoyl-estrone, its experimental obesity drug, was shown to be safe with no serious adverse events noted in a...
Manhattan Pharmaceuticals Hires Redington, Inc. to Expand Reach in U.S. Investment Community
01 sept. 2005 10h02 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Sept. 1, 2005 (PRIMEZONE) -- In an effort to expand its reach and raise awareness in the U.S. investment community, Manhattan Pharmaceuticals, Inc (OTCBB:MHTT) said it retained Redington,...
Manhattan Pharmaceuticals to Present at Oppenheimer Diabetes Conference
31 août 2005 11h27 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 31, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) announced that Douglas Abel, president and chief executive officer, will present an overview of the company and its...
Manhattan Pharmaceuticals Raises $11.9 Million in Private Placement
30 août 2005 09h30 HE
|
Manhattan Pharmaceuticals, Inc.
NEW YORK, Aug. 30, 2005 (PRIMEZONE) -- Manhattan Pharmaceuticals, Inc. (OTCBB:MHTT) completed a private placement of common stock and warrants to institutional and accredited investors resulting in...